ClinicalTrials.gg
RecruitingNCT05365282ACCESS-IVUpdated Apr 23, 2026

Association Between Radial Artery Intervention and Development of Neuropathy in the Hand - A Prospective Study

An observational study in Ischemic Heart Disease, Nerve Injury and Carpal Tunnel Syndrome, sponsored by Aarhus University Hospital Skejby. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by Aarhus University Hospital Skejby · Observational

How we know

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 95 studies in Myocardial Ischemia with a site in Denmark — 20 open to participants now, 25 under way, 2 of them phase 3. Myocardial Ischemia · Denmark.

Planned enrollment
8th of 20
400 · median 215
Started
2024
with 5 others
Observational
20 of 95
6 open now
Primary completion
2028-03
later than 16 of 24 live
Registered
76th of 95
by date
Lead sponsor
9 of 95
Aarhus University Hospital Skejby

Among the 95 studies in Myocardial Ischemia with a site in Denmark, this one is the 8th largest by planned enrollment of the 20 observational ones that give a count, is one of 6 that started in 2024, is one of 20 observational ones, reaches primary completion later than 16 of the 24 other live ones, and was the 76th registered.

Myocardial Ischemia

1,123 studies on the registry are indexed under Myocardial Ischemia; 177 are open to participants now.

Browse Myocardial Ischemia studies →

Open to participants now

20 of the 95 studies in Myocardial Ischemia with a site in Denmark are open now. Recruiting first, the newest first:

14 more — sign in →

All 20 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 135 Myocardial Ischemia studies recruiting now, 92 (68%) set no upper age limit and 6 (4%) stop at 75 or younger; 14 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 95 studies in Myocardial Ischemia with a site in Denmark, or all of them as a file.
02

Study summary

Evaluation of potential nerve damage after radial CAG/PCI.

Read the detailed description

Prospective patients scheduled for radial CAG/ PCI will be enrolled in the study. Prior to the procedure, sensory and motor nerve examination is performed at the wrists in both arms / hands. The examination is performed on both the median nerve and the ulnar nerve. Each patient acts as their own control. The nerve test is repeated bilaterally 1 month after the procedure. This creates 2 groups, A and B.

Patients will be asked to complete 2 questionnaires in relation to hand and arm symptoms. The patients ability to perform certain activities before and after the CAG/PCI procedure are also addressed. In addition, a diagnostic tool (Katz chart) will be completed, also before and after the CAG/PCI procedure.

Hypothesis:

Radial access is associated with an increased risk of pain and an increased incidence of nerve damage similar to the median nerve at the carpal tunnel or the ulnar nerve at the Guyon's canal.

03

Conditions studied

  • Ischemic Heart Disease
  • Nerve Injury
  • Carpal Tunnel Syndrome

Keywords

  • Transradial access
  • Ischemic Heart Disease
  • Hand Dysfunction
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients suspected of ischemic heart disease scheduled for radial CAG/PCI at Aarhus University Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patient must be able to give

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Negative Barbeau test
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group A

    Access pathway a. radialis (right or left) and neurophysiological measurements of the same hand (ipsilateral intervention group).

  • Group B

    Access pathway a.radialis (right or left) and neurophysiological measurements of opposite hand (contralateral intervention group).

06

What researchers measure

Primary outcomes

  1. Neurophysiological measurements

    The primary aim is the incidence/presence of electrofysiological signs of median and/or ulnar nerve lesion at the wrist and the presence of carpaltunnel syndrom. The electrodiagnosis of carpaltunnelsyndrom will be determined from the clinical picture and signs of prolonged distal motor lantency and reduced motor and sensory nerveconduction velocity across the wrist and/or reduced amplitudes of the median nerve and normal ulnar nerve at the wrist.

    Time frame: Aprox 1 hour

Secondary outcomes

  1. Severity of hand symptoms and hand dysfunction

    Boston questionaire

    Time frame: 10min

  2. Severity of hand symptoms and hand dysfunction

    QuickDash questionaire

    Time frame: 10 min

07

Study locations

1 of 1 sites recruiting
  • Department of cardiology, Aarhus University Hospital in Skejby
    Aarhus, 8200, Denmark
    Recruiting
    • Christian J Terkelsen, MD,PhD · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Mar 2028, 50 months after the start.

Of 165 non-industry observational studies under Myocardial Ischemia, half reached primary completion within 51 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 127. This study's planned 50 months is close to that.

Counting every sponsor, half of 204 studies reached it within 40 months; a quarter within 21 and three quarters within 90.

How these figures are worked out, and which studies are left out of them.

Registered
May 4, 2022
First posted
May 9, 2022
StartActual
Jan 1, 2024
Primary completionEst.
Mar 1, 2028
CompletionEst.
Dec 1, 2028
Last update
Apr 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05365282
Lead sponsor
Aarhus University Hospital Skejby
Responsible party
Christian Juhl Terkelsen (Professor, Professor, Chief Physician, PhD., Aarhus University Hospital Skejby) — Principal investigator
First posted
May 9, 2022
Start date
Jan 1, 2024
Primary completion
Mar 1, 2028 (estimated)
Completion
Dec 1, 2028 (estimated)
Last update
Apr 23, 2026

Study contacts

Christel G Aagren Nielsen
Contact
chisnils@rm.dk
+45 78452213
Christian J Terkelsen, Professor
Contact
Chriterk@rm.dk
78452017
Christian J Terkelsen, Professor
study chair · Aarhus University Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion